Impax Labs Opana ER Gets Final FDA Approval
Impax Laboratories had received final approval for the 5mg, 10mg, 20mg, and 40mg tablet strengths in June 2010. Opana is in a group of drugs called narcotic pain
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.